# Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes

Review · Manoj Kumar Mahapatra, Muthukumar Karuppasamy, Biswa Mohan Sahoo

- Archive id: doi:10.1007/s11154-021-09699-1
- Published: 2022-01-07
- Venue: Reviews in Endocrine and Metabolic Disorders
- DOI: https://doi.org/10.1007/s11154-021-09699-1
- PMID: 34993760
- Citations: 166
- Source URL: https://doi.org/10.1007/s11154-021-09699-1
- PDF: https://link.springer.com/content/pdf/10.1007/s11154-021-09699-1.pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.